
LENZ Therapeutics, Inc.
USD7.01
-0.12 (-1.68%)
CEO
Evert Schimmelpennink
IPO Date
2024-03-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.00
Prev. Close
$7.13
Day Low
$6.96
Day High
$7.17
52W Low
$6.61
52W High
$50.40
Market Cap
$0.22B
Volume
0.51M
| 21 Apr 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 26 Mar 2026 | Citigroup | Buy | Buy | maintain |
| 25 Mar 2026 | B of A Securities | Buy | Buy | maintain |
| 20 Oct 2025 | Raymond James | Outperform | Outperform | maintain |
| 10 Oct 2025 | Piper Sandler | Overweight | Overweight | maintain |
| 1 Aug 2025 | Citigroup | Buy | Buy | maintain |
| 1 Aug 2025 | HC Wainwright & Co. | Buy | Buy | maintain |